Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | ||
Ligand | BDBM50031890 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_213117 (CHEMBL818196) | ||
IC50 | 8±n/a nM | ||
Citation | Jones, CD; Audia, JE; Lawhorn, DE; McQuaid, LA; Neubauer, BL; Pike, AJ; Pennington, PA; Stamm, NB; Toomey, RE; Hirsch, KS Nonsteroidal inhibitors of human type I steroid 5-alpha-reductase. J Med Chem36:421-3 (1993) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | |||
Name: | 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | ||
Synonyms: | 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 5 alpha-SR2 | 5α-Reductase 2 (5α-R2) | S5A2_HUMAN | SR type 2 | SRD5A2 | Steroid 5-alpha-reductase | Steroid 5-alpha-reductase 2 | Type II 5-alpha reductase | ||
Type: | Enzyme | ||
Mol. Mass.: | 28406.59 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P31213 | ||
Residue: | 254 | ||
Sequence: |
| ||
BDBM50031890 | |||
n/a | |||
Name | BDBM50031890 | ||
Synonyms: | (10R,13S)-17-tert-Butylcarbamoyl-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylic acid | (10R,13S,17S)-17-Diisopropylcarbamoyl-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylic acid | (10R,13S,17S)-17-tert-Butylcarbamoyl-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylic acid | (10R,14S)-17-tert-Butylcarbamoyl-10-methyl-13-(S)-methyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylic acid | 17-tert-Butylcarbamoyl-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylic acid | CHEMBL290823 | Epristeride | ||
Type | Small organic molecule | ||
Emp. Form. | C25H37NO3 | ||
Mol. Mass. | 399.5662 | ||
SMILES | [H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C=C(CC[C@]12C)C(O)=O |r,c:25,t:23| | ||
Structure |